SAB Biotherapeutics Announces Q1 2024 Financial Results and Provides Company Updates
20. Mai 2024 17:45 ET
|
SAB Biotherapeutics, Inc.
SAB Biotherapeutics Announces Q1 2024 Financial Results
Wilhelm Sonesson Offers Shareholders Opportunity to Acquire Other Operations
25. März 2002 12:41 ET
|
Wilhelm Sonesson
MALMO, Sweden, March 25, 2002 (PRIMEZONE) -- The Board of Wilhelm Sonesson has resolved to recommend to the Annual General Meeting on April 24, 2002 a division of current operations into two separate...